Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
The Smithsonian Institution is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 matters are split between 2 distinct examiners and 2 distinct art units. LANDAU, SHARMILA GOLLAMUDI is the busiest examiner for the portfolio, holding 1 pending action.
With 2 pending office actions spread across 2 distinct art units, the practitioner must manage separate prosecution tracks. The involvement of 2 distinct examiners means that the strategy used for LANDAU, SHARMILA GOLLAMUDI may not be applicable to the other pending matter. This distribution suggests the Smithsonian is pursuing diverse technological applications within the broad field of biotechnology. Practitioners should be prepared for different examination styles, as the 2 distinct examiners may have varying interpretations of patentability. This lack of concentration requires a flexible approach that can adapt to the unique requirements of 2 separate art units simultaneously. Success in 1 track will not necessarily guarantee success in the other, especially with 1 pending action per examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANDAU, SHARMILA GOLLAMUDI | 1 | 11.1% | +4.6% |
| HANSEN, JAMES ORVILLE | 1 | 70.5% | +21.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17576894 | SYSTEM AND METHOD FOR EXHIBITING DIVERSE PRODUCTS WITH A LABEL RAIL SYSTEM | HANSEN, JAMES ORVILLE | 8d overdue |
| 17726271 | Cryopreservation compositions and methods involving nanowarming | LANDAU, SHARMILA GOLLAMUDI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17576894 | SYSTEM AND METHOD FOR EXHIBITING DIVERSE PRODUCTS WITH A LABEL RAIL SYSTEM | HANSEN, JAMES ORVILLE | 8d overdue |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 3637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17726271 | Cryopreservation compositions and methods involving nanowarming | LANDAU, SHARMILA GOLLAMUDI | 1653 | DP | Final Rejection | — | Pending | Apr 21, 2022 |
| 17576894 | SYSTEM AND METHOD FOR EXHIBITING DIVERSE PRODUCTS WITH A LABEL RAIL SYSTEM | HANSEN, JAMES ORVILLE | 3637 | §103§112 | Final Rejection | 8d overdue | Pending | Jan 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial